Annexin A2 Antikörper

Produktnummer ABIN3022160

Produktdetails anti-Annexin A2 Antikörper

Target: Annexin A2 (ANXA2)

Reaktivität: Human, Maus, Ratte

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser Annexin A2 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunohistochemistry (IHC)

Aufreinigung: Affinity purification

Immunogen: Recombinant protein of human ANXA2

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Recommended dilutions: WB: 1:500-1:2000, IHC: 1:50-1:200

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: Avoid freeze / thaw cycles

Lagerung: -20 °C/-80 °C

Details zu Annexin A2

Target: Annexin A2 (ANXA2)

Andere Bezeichnung: ANXA2 (ANXA2 Produkte)

Synonyme: ANX2 antikoerper, ANX2L4 antikoerper, CAL1H antikoerper, LIP2 antikoerper, LPC2 antikoerper, LPC2D antikoerper, P36 antikoerper, PAP-IV antikoerper, AW215814 antikoerper, Cal1h antikoerper, p36 antikoerper, anx2 antikoerper, lip2 antikoerper, lpc2 antikoerper, cal1h antikoerper, lpc2d antikoerper, pap-i antikoerper, anx2l4 antikoerper, MGC76145 antikoerper, ANXA2 antikoerper, anxa2 antikoerper, anxa2-a antikoerper, anxa2-b antikoerper, annexin A2 antikoerper, annexin A2 S homeolog antikoerper, ANXA2 antikoerper, Anxa2 antikoerper, anxa2 antikoerper, anxa2.S antikoerper

Hintergrund: Annexin A2 (ANXA2), also known as lipocortin II or calpactin-1 heavy chain, is a 36 kDa member of the annexin superfamily that binds phospholipids and other proteins in a calcium-dependent manner via annexin repeats. Annexin A2 contains four such repeats through which it mediates protein-protein and protein-lipid interactions. It forms a constitutive heterotetramer with S100A10, acting as a bridge between the actin cytoskeleton, plasma membrane, and endocytotic vesicle machinery. Originally identified as a protein inhibitor of phospholipase A2, annexin A2 has subsequently been shown to interact with an array of protein and non-protein partners, including F-actin, spectrin, SNARE complexes, RNA, and virus particles. Annexin A2 has also been shown to have receptor-like activity and is detected on the surface of macrophages and vascular endothelial cells where it mediates macrophage activation and Factor Xa signaling, respectively. Upregulation of annexin A2 at the cell surface is thought to be modulated by phosphorylation at Tyr23 by Src. Interestingly, phosphorylation at Tyr23 has recently been shown to be required for cell surface expression of annexin A2 where it mediates motility, invasiveness, and overall metastatic potential of certain pancreatic cancer cells. Annexin A2 has also been shown to be heavily phosphorylated on serine residues in response to PKC activation via a pleiotropic mechanism. For a complete list of curated phosphorylation sites on annexin A2, please see PhosphoSitePlus® at www.phosphosite.org.
Synonyms: ANX2, ANX2L4, CAL1H, LIP2, LPC2, LPC2D, P36, PAP-IV

Gen-ID: 302

UniProt: P07355

Pathways: S100 Proteine